Cas no 79950-85-9 (Sorbicillin)
Sorbicillin Chemical and Physical Properties
Names and Identifiers
-
- Sohirnone B
- (2E,4E)-1-(2,4-dihydroxy-3,5-dimethylphenyl)hexa-2,4-dien-1-one
- 2,4-hexadien-1-one, 1-(2,4-dihydroxy-3,5-dimethylphenyl)-, (2E,4E)-
- 3-Hydroxy-2,4-dimethyl-6-(1-oxo-hexa-2,4-dienyl)phenol
- Sorbicillin
- CHEMBL4437946
- NS00097316
- SCHEMBL3122114
- RKKPUBAAIGFXOG-YTXTXJHMSA-N
- (2E,4E)-1-(2,4-Dihydroxy-3,5-dimethylphenyl)-2,4-hexadien-1-one #
- MS-23330
- HY-146748
- 2,4-Hexadien-1-one, 1-(2,4-dihydroxy-3,5-dimethylphenyl)-, (E,E)-
- Osrbicilin
- 2V94TML24G
- ACon1_001459
- BRD-K91836452-001-01-3
- AKOS040734339
- MEGxm0_000242
- DTXSID601347883
- ACon0_000046
- Q27255645
- (2E,4E)-1-(2,4-Dihydroxy-3,5-dimethylphenyl)-2,4-hexadien-1-one
- CHEBI:167836
- CS-0438616
- NCGC00180484-01
- UNII-2V94TML24G
- 79950-85-9
- DA-77932
-
- Inchi: 1S/C14H16O3/c1-4-5-6-7-12(15)11-8-9(2)13(16)10(3)14(11)17/h4-8,16-17H,1-3H3/b5-4+,7-6+
- InChI Key: RKKPUBAAIGFXOG-YTXTXJHMSA-N
- SMILES: OC1C(C)=CC(C(/C=C/C=C/C)=O)=C(C=1C)O
Computed Properties
- Exact Mass: 232.109944368g/mol
- Monoisotopic Mass: 232.109944368g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 17
- Rotatable Bond Count: 3
- Complexity: 319
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 2
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.6
- Topological Polar Surface Area: 57.5?2
Sorbicillin Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| MedChemExpress | HY-146748-10mM*1mLinDMSO |
Sorbicillin |
79950-85-9 | 99.85% | 10mM*1mLinDMSO |
¥1650 | 2023-07-25 | |
| MedChemExpress | HY-146748-5mg |
Sorbicillin |
79950-85-9 | 99.85% | 5mg |
¥1500 | 2025-04-16 | |
| MedChemExpress | HY-146748-10mg |
Sorbicillin |
79950-85-9 | 99.85% | 10mg |
¥2500 | 2025-04-16 | |
| MedChemExpress | HY-146748-25mg |
Sorbicillin |
79950-85-9 | 99.85% | 25mg |
¥5500 | 2025-04-16 | |
| MedChemExpress | HY-146748-50mg |
Sorbicillin |
79950-85-9 | 99.85% | 50mg |
¥9500 | 2024-07-20 | |
| MedChemExpress | HY-146748-100mg |
Sorbicillin |
79950-85-9 | 99.85% | 100mg |
¥15000 | 2023-08-31 | |
| MedChemExpress | HY-146748-10mM*1 mL in DMSO |
Sorbicillin |
79950-85-9 | 99.85% | 10mM*1 mL in DMSO |
¥1650 | 2025-04-16 | |
| MedChemExpress | HY-146748-1mg |
Sorbicillin |
79950-85-9 | 99.85% | 1mg |
¥681 | 2025-04-16 | |
| 1PlusChem | 1P00GHZN-5mg |
Sohirnone B |
79950-85-9 | 99% | 5mg |
$202.00 | 2024-04-21 | |
| 1PlusChem | 1P00GHZN-10mg |
Sohirnone B |
79950-85-9 | 99% | 10mg |
$313.00 | 2024-04-21 |
Sorbicillin Suppliers
Sorbicillin Related Literature
-
Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752
-
James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156
-
Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227
-
Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
-
Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
Additional information on Sorbicillin
Introduction to Sorbicillin (CAS No. 79950-85-9)
Sorbicillin, a compound with the chemical identifier CAS No. 79950-85-9, has garnered significant attention in the field of chemical and biomedical research due to its unique structural properties and potential applications. This introduction delves into the compound's characteristics, its significance in modern research, and its emerging role in pharmaceutical development.
The molecular structure of Sorbicillin is characterized by its complex and highly functionalized framework, which contributes to its diverse range of biological activities. Recent studies have highlighted its potential as a bioactive molecule, particularly in the context of antimicrobial and anti-inflammatory applications. The compound's ability to interact with biological targets at a molecular level has made it a subject of intense interest among researchers.
In the realm of pharmaceutical research, Sorbicillin has been explored for its capacity to modulate various cellular pathways. Its mechanism of action involves intricate interactions with enzymes and receptors, which are pivotal in maintaining cellular homeostasis. This has led to investigations into its potential use in treating a variety of diseases, including those associated with oxidative stress and inflammation.
One of the most compelling aspects of Sorbicillin is its stability under a range of environmental conditions, which enhances its suitability for industrial and pharmaceutical applications. This stability is attributed to its robust chemical bonds and resistant functional groups, making it a reliable candidate for formulation in drug delivery systems.
Recent advancements in synthetic chemistry have enabled the development of novel derivatives of Sorbicillin, each with enhanced properties tailored for specific therapeutic purposes. These derivatives are being tested in preclinical studies to evaluate their efficacy and safety profiles. The results have been promising, suggesting that these modified compounds could offer new treatment options for various medical conditions.
The application of computational methods has also played a crucial role in understanding the behavior of Sorbicillin at both molecular and cellular levels. High-resolution simulations have provided insights into how the compound interacts with biological targets, aiding in the design of more effective therapeutic agents.
Furthermore, the environmental impact of using Sorbicillin as a bioactive compound has been a focus of research. Studies have demonstrated that it can be efficiently degraded under natural conditions, minimizing potential ecological risks. This biodegradability makes it an attractive option for sustainable pharmaceutical development.
The integration of nanotechnology with traditional drug delivery systems has opened new avenues for utilizing Sorbicillin. Nanoparticle-based formulations have shown enhanced bioavailability and targeted delivery, improving therapeutic outcomes. These innovations are particularly relevant in addressing challenges associated with drug resistance and poor patient compliance.
As research continues to uncover the multifaceted properties of Sorbicillin, its potential applications are expected to expand further. The compound's versatility makes it a valuable asset in the quest for novel therapeutic solutions, particularly in areas where traditional treatments have limitations.
In conclusion, Sorbicillin (CAS No. 79950-85-9) represents a significant advancement in chemical and biomedical research. Its unique properties and broad spectrum of activities position it as a promising candidate for future pharmaceutical developments. The ongoing studies and innovations surrounding this compound underscore its importance in addressing contemporary challenges in medicine and biotechnology.
79950-85-9 (Sorbicillin) Related Products
- 136054-85-8(2,4-Pentadien-1-one, 1-(2-hydroxyphenyl)-5-phenyl-, (2E,4E)-)
- 41420-57-9((2E,4E)-1-(2-hydroxyphenyl)-5-phenylpenta-2,4-dien-1-one)
- 57309-79-2( )
- 118024-33-2(2,4-Pentadien-1-one,1-(5-acetyl-2,4-dihydroxyphenyl)-5-phenyl-)
- 106167-57-1(2,4-Hexadien-1-one, 1-(2,4-dihydroxyphenyl)-)
- 488799-91-3
- 5631-63-0(2-Buten-1-one, 1-(2-hydroxy-5-methylphenyl)-)
- 106381-22-0(2,4-Hexadien-1-one, 1-(2-hydroxy-4-methoxyphenyl)-)
- 140660-42-0(2-Buten-1-one, 1-(2,5-dihydroxyphenyl)-)
- 2552-56-9(2,4-Pentadien-1-one, 1-(2-hydroxy-5-methylphenyl)-5-phenyl-)